Rexulti Dosage Strengths
Rexulti (brexpiprazole) is available in six tablet strengths: 0.25 mg, 0.5 mg, 1 mg, 2 mg, 3 mg, and 4 mg 1.
Tablet Identification
Each strength has distinct visual characteristics for easy identification:
- 0.25 mg: Light brown, round tablets with "BRX" and "0.25" imprinted
- 0.5 mg: Light orange, round tablets with "BRX" and "0.5" imprinted
- 1 mg: Light yellow, round tablets with "BRX" and "1" imprinted
- 2 mg: Light green, round tablets with "BRX" and "2" imprinted
- 3 mg: Light purple, round tablets with "BRX" and "3" imprinted
- 4 mg: White, round tablets with "BRX" and "4" imprinted
All tablets share the same physical characteristics: round, shallow convex, bevel-edged body with markings on one side 1.
Clinical Context
The range of available strengths allows for precise dose titration across Rexulti's approved indications, which include schizophrenia, adjunctive treatment of major depressive disorder, and agitation associated with Alzheimer's disease dementia 1. The lower strengths (0.25 mg and 0.5 mg) are particularly important for initial titration, as the recommended starting dose for agitation in Alzheimer's disease is 0.5 mg daily, with gradual increases to the target dose of 2 mg 1.